Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma

被引:2
作者
Hori, Tomohide [1 ]
Onishi, Yasuharu [1 ]
Kamei, Hideya [1 ]
Kurata, Nobuhiko [1 ]
Ishigami, Masatoshi [1 ]
Ishizu, Yoji [1 ]
Ogura, Yasuhiro [1 ]
机构
[1] Nagoya Univ Hosp, Dept Transplant Surg, Nagoya, Aichi, Japan
关键词
Hepatitis; Hepatitis C; Liver Failure; Liver Transplantation;
D O I
10.12659/AJCR.898427
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Challenging differential diagnosis Background: Hepatitis C recurrence is a serious matter after liver transplantation (LT). Approximately 10% of hepatitis C virus (HCV) positive recipients develop fibrosing cholestatic hepatitis (FCH). FCH rapidly results in graft loss. Currently, direct-acting antivirals (DAAs) are effective and safe for hepatitis C, even after LT. However, only a few cases of successfully treated FCH after LT have been reported. We present FCH in a complicated case with sepsis and portal flow obstruction after LT. Case Report: A 66-year-old man underwent cadaveric LT. Liver function disorders were observed from post-operative day (POD) 22. Sepsis repeated on POD 38, 74, and 101. Steroid pulse therapy was given from POD 40 to 54. The infectious focus was surgically removed on POD 89. Interventional radiology for portal venous obstruction was completed on POD 96. To make a real-time diagnosis and to investigate the graft condition, repeat liver needle biopsies (LNBs) were taken. Although there was a combined impact of sepsis, portal flow decrease, and recurrent hepatitis C on graft failure, it was interesting that recurrent hepatitis C was consistently detectable from the first LNB. HCV-ribonucleic acid increased on POD 68. Liver function disorders peaked on POD 71 and 72. Jaundice peaked on POD 82. DAA induction was regrettably delayed because of a reluctance to introduce DAAs under conditions of graft dysfunction. DAAs were administered after hospital discharge. Conclusions: A real-time and precise diagnosis based on histopathological examination and viral measurement is important for FCH treatment. Well-considered therapy with DAAs should be aggressively introduced for potentially fatal FCH after LT.
引用
收藏
页码:597 / 604
页数:8
相关论文
共 24 条
[1]  
Al Nahdi N, 2013, ANN HEPATOL, V12, P156
[2]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[3]   The Model for the End-Stage Liver Disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding [J].
Benedeto-Stojanov, Daniela ;
Nagorni, Aleksandar ;
Bjelakovic, Goran ;
Stojanov, Dragan ;
Mladenovic, Bojan ;
Djenic, Nebojsa .
VOJNOSANITETSKI PREGLED, 2009, 66 (09) :724-728
[4]   HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].
Berenguer, M ;
Ferrell, L ;
Watson, J ;
Prieto, M ;
Kim, M ;
Rayón, M ;
Córdoba, J ;
Herola, A ;
Ascher, N ;
Mir, J ;
Berenguer, J ;
Wright, TL .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684
[5]   Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients [J].
Berenguer, Marina ;
Aguilera, Victoria ;
Prieto, Martin ;
San Juan, Fernando ;
Rayon, Jose M. ;
Benlloch, Salvador ;
Berenguer, Joaquin .
LIVER TRANSPLANTATION, 2006, 12 (05) :762-767
[6]   Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation [J].
Blasco, A ;
Forns, X ;
Carrión, JA ;
García-Pagán, JC ;
Gilbert, R ;
Rimola, A ;
Nbquel, R ;
Bruguera, M ;
García-Valdecasas, JC ;
Bosch, J ;
Navasa, M .
HEPATOLOGY, 2006, 43 (03) :492-499
[7]  
Child C, 1964, SURG PORTAL HYPERTEN, P50
[8]   Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients [J].
Cholongitas, Evangelos ;
Pipili, Chrysoula ;
Papatheodoridis, George .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) :9526-9533
[9]   Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation [J].
Delabaudiere, Cyrielle ;
Lavayssiere, Laurence ;
Doerr, Gaelle ;
Muscari, Fabrice ;
Danjoux, Marie ;
Sallusto, Federico ;
Peron, Jean Marie ;
Bureau, Christophe ;
Rostaing, Lionel ;
Izopet, Jacques ;
Kamar, Nassim .
TRANSPLANT INTERNATIONAL, 2015, 28 (02) :255-258
[10]   Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation [J].
Forns, Xavier ;
Charlton, Michael ;
Denning, Jill ;
McHutchison, John G. ;
Symonds, William T. ;
Brainard, Diana ;
Brandt-Sarif, Theo ;
Chang, Paul ;
Kivett, Valerie ;
Castells, Lluis ;
Prieto, Martin ;
Fontana, Robert J. ;
Baumert, Thomas F. ;
Coilly, Audrey ;
Carlota Londono, Maria ;
Habersetzer, Francois .
HEPATOLOGY, 2015, 61 (05) :1485-1494